Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 2,562,600 | 4,056,900 | 2,150,800 | 2,667,200 | 2,655,100 |
| Cost of Goods | 1,020,100 | 1,831,300 | 1,183,100 | 1,296,500 | 1,293,000 |
| Gross Profit | 1,542,500 | 2,225,600 | 967,700 | 1,370,700 | 1,362,100 |
| Operating Expenses | 2,220,300 | 2,820,900 | 2,249,800 | 1,165,100 | 1,154,200 |
| Operating Income | -677,700 | -629,600 | -1,282,000 | 206,100 | 207,900 |
| Interest Expense | 171,900 | 127,800 | 132,100 | 79,100 | 72,800 |
| Other Income | -196,100 | -37,500 | 31,000 | -34,600 | 6,000 |
| Pre-tax Income | -1,045,700 | -794,900 | -1,383,100 | 92,400 | 141,100 |
| Income Tax | -259,000 | -62,000 | -221,000 | 43,600 | 44,400 |
| Net Income Continuous | -786,700 | -732,900 | -1,162,100 | 48,800 | 96,700 |
| Net Income Discontinuous | 274,400 | 734,800 | 119,300 | N/A | N/A |
| Minority Interests | -300 | N/A | N/A | 100 | 200 |
| Net Income | $-512,000 | $-732,900 | $-1,042,800 | $48,700 | $96,500 |
| EPS Basic Total Ops | -1.85 | -2.76 | -3.95 | 0.28 | 0.56 |
| EPS Basic Continuous Ops | -2.80 | -2.76 | -4.40 | 0.28 | 0.56 |
| EPS Basic Discontinuous Ops | 0.95 | 3.44 | 0.45 | N/A | N/A |
| EPS Diluted Total Ops | -1.85 | -2.76 | -3.95 | 0.28 | 0.55 |
| EPS Diluted Continuous Ops | -2.80 | -2.76 | -4.40 | 0.28 | 0.55 |
| EPS Diluted Discontinuous Ops | 0.95 | 3.44 | 0.45 | N/A | N/A |
| EBITDA(a) | $814,900 | $702,500 | $161,200 | $758,300 | $816,400 |